David J Scott - Net Worth and Insider Trading

David J Scott Net Worth

The estimated net worth of David J Scott is at least $20 Million dollars as of 2025-07-14. David J Scott is the SVP, Gen. Counsel & Secy. of Amgen Inc and owns about 67,190 shares of Amgen Inc (AMGN) stock worth over $20 Million. David J Scott is also the Sr VP, Genl Counsel & Corp Sec of Medtronic PLC and owns about 3,386 shares of Medtronic PLC (MDT) stock worth over $304,469. Details can be seen in David J Scott's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David J Scott has not made any transactions after 2012-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David J Scott

David J Scott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David J Scott owns 1 companies in total, including Amgen Inc (AMGN) .

Click here to see the complete history of David J Scott’s form 4 insider trades.

Insider Ownership Summary of David J Scott

Ticker	Company	Transaction Date	Type of Owner
AMGN	Amgen Inc	2012-01-27	Sr. VP & Gen. Counsel & Secy.

David J Scott Latest Holdings Summary

David J Scott currently owns a total of 2 stocks. Among these stocks, David J Scott owns 67,190 shares of Amgen Inc (AMGN) as of January 27, 2012, with a value of $20 Million and a weighting of 98.49%. David J Scott also owns 3,386 shares of Medtronic PLC (MDT) as of January 12, 2004, with a value of $304,469 and a weighting of 1.51%.

Latest Holdings of David J Scott

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AMGN	Amgen Inc	2012-01-27	67,190	295.27	19,839,191
MDT	Medtronic PLC	2004-01-12	3,386	89.92	304,469

Holding Weightings of David J Scott

David J Scott Form 4 Trading Tracker

According to the SEC Form 4 filings, David J Scott has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 133,500 shares on January 27, 2012, which brought David J Scott around $9 Million.

According to the SEC Form 4 filings, David J Scott has made a total of 0 transactions in Medtronic PLC (MDT) over the past 5 years. The most-recent trade in Medtronic PLC is the sale of 138,000 shares on January 12, 2004, which brought David J Scott around $7 Million.

Insider Trading History of David J Scott

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David J Scott Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David J Scott Ownership Network

Ownership Network List of David J Scott

No Data

Ownership Network Relation of David J Scott

David J Scott Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

David J Scott is the Sr. VP & Gen. Counsel & Secy. of Amgen Inc. Other key executives at Amgen Inc include SVP & Business Development Rachna Khosla , VP & Finance & CAO Matthew C. Busch , and EVP & Research and Development David M Reese .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, David J Scott made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 3,706 shares made by Nancy A. Grygiel , a net sale of 33,936 shares made by David M Reese , and a net sale of 25,045 shares made by Jonathan P Graham .

In summary, during the past 3 months, insiders sold 2,500 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 84,693 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 84,693 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amgen Inc Insider Transactions

No Available Data

David J Scott Mailing Address

Above is the net worth, insider trading, and ownership report for David J Scott. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David J Scott's mailing address is: Thousand Oaks Ca 91320-1799.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.